세계의 심혈관 정보 시스템 시장 규모, 점유율, 산업 동향 분석 리포트 : 유형별, 동작 모드별, 지역별 전망과 예측(2023-2030년)

The Global Cardiovascular Information System Market size is expected to reach $2.2 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.

Over the forecast period, it is anticipated that the presence of quickly developing economies like China and India, where the healthcare system is rapidly improving, will accelerate the region's development. Thus, the Asia Pacific region would generate 25% share of the market by 2030. Due to a sharp rise in the number of patients, the region has seen a significant increase in healthcare spending, which has increased investments in R&D activities pertaining to cardiovascular diseases. Due to the development of novel and cutting-edge goods and technologies, the regional market has grown faster.

The major strategies followed by the market participants are Acquisitions as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, McKesson Corporation announced the acquisition of Rx Savings Solutions, to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements. Additionally, Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, to further build out its Learning Health Network consortium.

Based on the Analysis presented in the KBV Cardinal matrix; Cisco Systems, Inc. and Oracle Corporation are the forerunners in the Market. In July, 2021, Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., to enhance Cisco Webex's platform offerings and would provide customers with a better experience in online events. Companies such as Honeywell International, Inc., McKesson Corporation, Siemens Healthineers AG are some of the key innovators in the Market.

COVID-19 Impact Analysis

Healthcare facilities faced financial constraints due to the pandemic. Many resources were diverted to address COVID-19, impacting the allocation of funds for other healthcare technologies. As a result, some healthcare providers deferred investments in CVIS or other non-urgent systems. The pandemic disrupted regular operations in healthcare facilities. This led to delays in the implementation of new technologies, including CVIS. Therefore, the pandemic had a comparatively positive impact on the market. The adoption of CVIS has become a key component in healthcare, leading to positive growth in the market in the coming years.

Market Growth Factors

Increased efficiency and workflow optimization

The emphasis on efficiency in healthcare has led to the adoption of CVIS systems that streamline clinical workflows, reducing administrative burdens and enhancing the overall efficiency of patient care. The market has responded to this demand by providing specialized solutions that automate various tasks related to data retrieval, test interpretation, and report generation. This optimization directly impacts patient outcomes, as it enables quicker diagnosis and treatment, resulting in improved clinical efficacy and satisfaction for healthcare providers and patients alike. Data-driven medicine has fueled the demand for advanced CVIS solutions that can efficiently capture, store, and manage vast amounts of patient data and diagnostic information. Therefore, the increasing demand for CVIS solutions that enable efficient data management and workflow optimization underscores these systems' pivotal role in modern healthcare delivery.

Expansion of healthcare infrastructure

Rapid population growth, particularly in urban areas, increases healthcare infrastructure demands. In order to accommodate the increasing number of patients looking for medical care, facilities, and services must be expanded. As the global population ages, there is a greater need for healthcare services to address age-related health issues and provide long-term care. Expanding healthcare infrastructure often includes establishing new cardiology departments and cardiovascular care facilities. CVIS solutions are instrumental in providing a comprehensive platform for managing patient data and diagnostic information efficiently within these departments. The expansion of healthcare infrastructure has bolstered the growth and significance of the market by creating a demand for specialized solutions that support the efficient management of cardiovascular patient data and diagnostic information.

Market Restraining Factors

High implementation costs and complexity

The high implementation costs associated with CVIS present a major hindrance to many healthcare facilities. These costs encompass the purchase of hardware and software and expenses related to customization, integration with existing systems, and comprehensive staff training. For smaller healthcare organizations or those operating with limited budgets, these financial requirements can be prohibitive, discouraging the adoption of CVIS. As a result, many healthcare providers are unable to access the advanced data management and diagnostic capabilities offered by CVIS, leading to a digital divide in healthcare services. These challenges hinder the expansion of the market, limiting the potential benefits these systems can offer in terms of streamlined data management, enhanced diagnostic capabilities, and improved patient care.

Type Outlook

On the basis of type, the market is classified into CVIS and CPACS. The CPACS segment recorded a significant revenue share in the market in 2022. The cardiovascular picture archiving and communication system (CPACS) is designed to manage cardiovascular images, including echocardiograms, angiograms, and nuclear medicine scans. It provides a secure repository for these images, making them readily accessible to healthcare professionals. CPACS ensures the quality and consistency of cardiovascular images, including image format, resolution, and compression, which is critical for accurate diagnosis and treatment planning.

Mode Of Operation Outlook

Based on mode of operation, the market is characterized into web-based, cloud-based, and on-site. The web-based segment garnered the highest revenue share in the market in 2022. Web-based CVIS is accessible from any internet-connected device with a web browser. This flexibility allows healthcare professionals to retrieve patient data and diagnostic information from different locations, promoting remote access and telemedicine. The initial costs of implementing web-based CVIS can be lower because it doesn't require extensive on-site infrastructure and hardware. This can make it more cost-effective, particularly for smaller healthcare institutions.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. According to the National Library of Medicine, differences in economic development, cultural practices, genetic predisposition, and trends in treatments and risk factors contribute to variations in heart failure rates across North America. The US and Canada are industrialized countries with similar geographic characteristics, economic and infrastructure systems, and cultural traditions.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation

Strategies Deployed in Cardiovascular Information System Market

Mergers & Acquisition:

Feb-2023: GE HealthCare Technologies, Inc. signed an agreement to acquire Caption Health, Inc., a healthcare technology company specializing in artificial intelligence-driven ultrasound guidance to improve the quality and accessibility of medical imaging. Through this acquisition, GE HealthCare would be focused on performing fundamental echocardiogram assessments and making it possible to identify early signs of conditions such as heart failure in high-risk individuals.

Sep-2022: McKesson Corporation announced the acquisition of Rx Savings Solutions (RxSS), a healthcare technology company specializing in innovative prescription drug cost-saving solutions for both consumers and employers. Through this partnership, McKesson Corporation would be able to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements.

Jul-2021: Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., an American event management platform provider. The acquisition enhances Cisco Webex's platform offerings and would provide customers with a better experience in online events.

Apr-2021: Siemens Healthineers AG acquired Varian Medical Systems, Inc., a global leader in cancer treatment solutions, providing advanced radiotherapy, radiosurgery, and brachytherapy technologies to improve the lives of cancer patients. Through this partnership, Siemens aimed to tackle the rising demand for personalized, data-informed diagnostics and precise cancer treatment, equipping us to combat the escalating global cancer epidemic.

Apr-2021: Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science industry, a division of Kantar Group. Through this acquisition, Cerner aimed to further build out its Learning Health Network consortium.

Feb-2021: Koninklijke Philips N.V. acquired BioTelemetry, Inc., a company that provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Through this acquisition, Philips would be able to provide their clients with healthcare solutions with a primary focus on cardiac patients and other medical conditions, both within the hospital and in the comfort of their homes.

Aug-2020: Koninklijke Philips N.V. took over Intact Vascular, Inc., a medical device company focused on developing innovative solutions for the treatment of peripheral artery disease. Through this acquisition, Philips would be able to offer more solutions for Peripheral Artery Disease.

Product Launches:

Feb-2023: Honeywell International, Inc. introduced Spectra MG BIO fibers, a bio-based variation of Spectra fibres, known for their exceptional strength, durability, and lightweight properties, used in various applications including ballistic protection and industrial use.

Partnerships, Collaborations & Agreements:

Jul-2023: GE HealthCare Technologies, Inc., came into partnership with Elekta, a leader in radiation therapy, in the Indian market. Through this partnership, GE HealthCare would aim to facilitate greater efficiency, precision, and personalization throughout the entire cancer care journey, emphasizing our commitment to investing in solutions that enhance the quality of cancer care while making it more patient cantered.

Oct-2022: GE Healthcare came into collaboration, both companies would advance their efforts to streamline the oncology care process, focusing on enhanced data handling, pathology digitization, and simplified data retrieval.

Oct-2022: Siemens Healthineers AG came into partnership with iMedrix Systems Pvt Ltd., a healthcare technology company specializing in remote patient monitoring solutions and telemedicine services. Through this partnership, both companies would provide telecardiology technology to help their clients generate deeper insights into health.

Sep-2022: McKesson Corporation partnered with CVS Health, a diversified healthcare company that operates pharmacies, healthcare clinics, and health insurance services, focusing on improving access to quality healthcare and pharmaceuticals. Through this partnership, both companies would be able to fulfil the growing customer demands.

Jul-2020: Cerner Corporation, a subsidiary of Oracle Corporation came into partnership with Holon Solutions, a healthcare technology company focused on data integration and interoperability solutions to improve healthcare delivery and patient outcomes. Through this partnership, Cerner accelerated the development of, seamless clinical decision support at the point of care.

Oct-2019: LUMEDX, a subsidiary of Intelerad Medical Systems Incorporated, came into partnership with MedAxiom, a US-Based Business Consulting and Services company. Through this partnership, LUMEDX would aim to accelerate the enhancement of the HealthView Analytics (HVA) platform to provide better patient outcomes and significant cost savings.

Scope of the Study

Market Segments covered in the Report:

By Type

• CVIS
• CPACS

By Mode Of Operation

• Web-based
• Cloud-based
• On-site

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Koninklijke Philips N.V.
• GE HealthCare Technologies, Inc.
• Cisco Systems, Inc.
• Fujifilm Holdings Corporation
• Siemens Healthineers AG (Siemens AG)
• Cerner Corporation (Oracle Corporation)
• Lumedx Corporation (Intelerad Medical Systems Incorporated)
• Agfa-Gevaert Group
• Honeywell International, Inc.
• McKesson Corporation

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Cardiovascular Information System Market, by Type
  • 1.4.2 Global Cardiovascular Information System Market, by Mode Of Operation
  • 1.4.3 Global Cardiovascular Information System Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
• 4.3 Market Share Analysis, 2022
• 4.4 Top Winning Strategies
  • 4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.4.2 Key Strategic Move: (Mergers & Acquisition: 2020, Aug - 2023, Feb) Leading Players
• 4.5 Porter Five Forces Analysis

Chapter 5. Global Cardiovascular Information System Market, by Type

• 5.1 Global CVIS Market, by Region
• 5.2 Global CPACS Market, by Region

Chapter 6. Global Cardiovascular Information System Market, by Mode Of Operation

• 6.1 Global Web-based Market, by Region
• 6.2 Global Cloud-based Market, by Region
• 6.3 Global On-site Market, by Region

Chapter 7. Global Cardiovascular Information System Market, by Region

• 7.1 North America Cardiovascular Information System Market
  • 7.1.1 North America Cardiovascular Information System Market, by Type
    • 7.1.1.1 North America CVIS Market, by Country
    • 7.1.1.2 North America CPACS Market, by Country
  • 7.1.2 North America Cardiovascular Information System Market, by Mode Of Operation
    • 7.1.2.1 North America Web-based Market, by Country
    • 7.1.2.2 North America Cloud-based Market, by Country
    • 7.1.2.3 North America On-site Market, by Country
  • 7.1.3 North America Cardiovascular Information System Market, by Country
    • 7.1.3.1 US Cardiovascular Information System Market
      • 7.1.3.1.1 US Cardiovascular Information System Market, by Type
      • 7.1.3.1.2 US Cardiovascular Information System Market, by Mode Of Operation
    • 7.1.3.2 Canada Cardiovascular Information System Market
      • 7.1.3.2.1 Canada Cardiovascular Information System Market, by Type
      • 7.1.3.2.2 Canada Cardiovascular Information System Market, by Mode Of Operation
    • 7.1.3.3 Mexico Cardiovascular Information System Market
      • 7.1.3.3.1 Mexico Cardiovascular Information System Market, by Type
      • 7.1.3.3.2 Mexico Cardiovascular Information System Market, by Mode Of Operation
    • 7.1.3.4 Rest of North America Cardiovascular Information System Market
      • 7.1.3.4.1 Rest of North America Cardiovascular Information System Market, by Type
      • 7.1.3.4.2 Rest of North America Cardiovascular Information System Market, by Mode Of Operation
• 7.2 Europe Cardiovascular Information System Market
  • 7.2.1 Europe Cardiovascular Information System Market, by Type
    • 7.2.1.1 Europe CVIS Market, by Country
    • 7.2.1.2 Europe CPACS Market, by Country
  • 7.2.2 Europe Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.2.1 Europe Web-based Market, by Country
    • 7.2.2.2 Europe Cloud-based Market, by Country
    • 7.2.2.3 Europe On-site Market, by Country
  • 7.2.3 Europe Cardiovascular Information System Market, by Country
    • 7.2.3.1 Germany Cardiovascular Information System Market
      • 7.2.3.1.1 Germany Cardiovascular Information System Market, by Type
      • 7.2.3.1.2 Germany Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.3.2 UK Cardiovascular Information System Market
      • 7.2.3.2.1 UK Cardiovascular Information System Market, by Type
      • 7.2.3.2.2 UK Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.3.3 France Cardiovascular Information System Market
      • 7.2.3.3.1 France Cardiovascular Information System Market, by Type
      • 7.2.3.3.2 France Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.3.4 Russia Cardiovascular Information System Market
      • 7.2.3.4.1 Russia Cardiovascular Information System Market, by Type
      • 7.2.3.4.2 Russia Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.3.5 Spain Cardiovascular Information System Market
      • 7.2.3.5.1 Spain Cardiovascular Information System Market, by Type
      • 7.2.3.5.2 Spain Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.3.6 Italy Cardiovascular Information System Market
      • 7.2.3.6.1 Italy Cardiovascular Information System Market, by Type
      • 7.2.3.6.2 Italy Cardiovascular Information System Market, by Mode Of Operation
    • 7.2.3.7 Rest of Europe Cardiovascular Information System Market
      • 7.2.3.7.1 Rest of Europe Cardiovascular Information System Market, by Type
      • 7.2.3.7.2 Rest of Europe Cardiovascular Information System Market, by Mode Of Operation
• 7.3 Asia Pacific Cardiovascular Information System Market
  • 7.3.1 Asia Pacific Cardiovascular Information System Market, by Type
    • 7.3.1.1 Asia Pacific CVIS Market, by Country
    • 7.3.1.2 Asia Pacific CPACS Market, by Country
  • 7.3.2 Asia Pacific Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.2.1 Asia Pacific Web-based Market, by Country
    • 7.3.2.2 Asia Pacific Cloud-based Market, by Country
    • 7.3.2.3 Asia Pacific On-site Market, by Country
  • 7.3.3 Asia Pacific Cardiovascular Information System Market, by Country
    • 7.3.3.1 China Cardiovascular Information System Market
      • 7.3.3.1.1 China Cardiovascular Information System Market, by Type
      • 7.3.3.1.2 China Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.3.2 Japan Cardiovascular Information System Market
      • 7.3.3.2.1 Japan Cardiovascular Information System Market, by Type
      • 7.3.3.2.2 Japan Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.3.3 India Cardiovascular Information System Market
      • 7.3.3.3.1 India Cardiovascular Information System Market, by Type
      • 7.3.3.3.2 India Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.3.4 South Korea Cardiovascular Information System Market
      • 7.3.3.4.1 South Korea Cardiovascular Information System Market, by Type
      • 7.3.3.4.2 South Korea Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.3.5 Singapore Cardiovascular Information System Market
      • 7.3.3.5.1 Singapore Cardiovascular Information System Market, by Type
      • 7.3.3.5.2 Singapore Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.3.6 Malaysia Cardiovascular Information System Market
      • 7.3.3.6.1 Malaysia Cardiovascular Information System Market, by Type
      • 7.3.3.6.2 Malaysia Cardiovascular Information System Market, by Mode Of Operation
    • 7.3.3.7 Rest of Asia Pacific Cardiovascular Information System Market
      • 7.3.3.7.1 Rest of Asia Pacific Cardiovascular Information System Market, by Type
      • 7.3.3.7.2 Rest of Asia Pacific Cardiovascular Information System Market, by Mode Of Operation
• 7.4 LAMEA Cardiovascular Information System Market
  • 7.4.1 LAMEA Cardiovascular Information System Market, by Type
    • 7.4.1.1 LAMEA CVIS Market, by Country
    • 7.4.1.2 LAMEA CPACS Market, by Country
  • 7.4.2 LAMEA Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.2.1 LAMEA Web-based Market, by Country
    • 7.4.2.2 LAMEA Cloud-based Market, by Country
    • 7.4.2.3 LAMEA On-site Market, by Country
  • 7.4.3 LAMEA Cardiovascular Information System Market, by Country
    • 7.4.3.1 Brazil Cardiovascular Information System Market
      • 7.4.3.1.1 Brazil Cardiovascular Information System Market, by Type
      • 7.4.3.1.2 Brazil Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.3.2 Argentina Cardiovascular Information System Market
      • 7.4.3.2.1 Argentina Cardiovascular Information System Market, by Type
      • 7.4.3.2.2 Argentina Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.3.3 UAE Cardiovascular Information System Market
      • 7.4.3.3.1 UAE Cardiovascular Information System Market, by Type
      • 7.4.3.3.2 UAE Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.3.4 Saudi Arabia Cardiovascular Information System Market
      • 7.4.3.4.1 Saudi Arabia Cardiovascular Information System Market, by Type
      • 7.4.3.4.2 Saudi Arabia Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.3.5 South Africa Cardiovascular Information System Market
      • 7.4.3.5.1 South Africa Cardiovascular Information System Market, by Type
      • 7.4.3.5.2 South Africa Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.3.6 Nigeria Cardiovascular Information System Market
      • 7.4.3.6.1 Nigeria Cardiovascular Information System Market, by Type
      • 7.4.3.6.2 Nigeria Cardiovascular Information System Market, by Mode Of Operation
    • 7.4.3.7 Rest of LAMEA Cardiovascular Information System Market
      • 7.4.3.7.1 Rest of LAMEA Cardiovascular Information System Market, by Type
      • 7.4.3.7.2 Rest of LAMEA Cardiovascular Information System Market, by Mode Of Operation

Chapter 8. Company Profiles

• 8.1 Koninklijke Philips N.V.
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Segmental and Regional Analysis
  • 8.1.4 Research & Development Expense
  • 8.1.5 Recent strategies and developments:
    • 8.1.5.1 Acquisition and Mergers:
  • 8.1.6 SWOT Analysis
• 8.2 GE HealthCare Technologies, Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Segmental and Regional Analysis
  • 8.2.4 Research & Development Expenses
  • 8.2.5 Recent strategies and developments:
    • 8.2.5.1 Partnerships, Collaborations, and Agreements:
    • 8.2.5.2 Acquisition and Mergers:
  • 8.2.6 SWOT Analysis
• 8.3 Cisco Systems, Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Financial Analysis
  • 8.3.3 Regional Analysis
  • 8.3.4 Research & Development Expense
  • 8.3.5 Recent strategies and developments:
    • 8.3.5.1 Acquisition and Mergers:
  • 8.3.6 SWOT Analysis
• 8.4 Fujifilm Holdings Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Segmental and Regional Analysis
  • 8.4.4 Research & Development Expenses
  • 8.4.5 SWOT Analysis
• 8.5 Siemens Healthineers AG (Siemens AG)
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Segmental and Regional Analysis
  • 8.5.4 Research & Development Expense
  • 8.5.5 Recent strategies and developments:
    • 8.5.5.1 Partnerships, Collaborations, and Agreements:
    • 8.5.5.2 Acquisition and Mergers:
  • 8.5.6 SWOT Analysis
• 8.6 Oracle Corporation (Cerner Corporation)
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Segmental and Regional Analysis
  • 8.6.4 Research & Development Expense
  • 8.6.5 Recent strategies and developments:
    • 8.6.5.1 Partnerships, Collaborations, and Agreements:
    • 8.6.5.2 Acquisition and Mergers:
  • 8.6.6 SWOT Analysis
• 8.7 Intelerad Medical Systems Incorporated (Lumedx Corporation)
  • 8.7.1 Company Overview
  • 8.7.2 Recent strategies and developments:
    • 8.7.2.1 Partnerships, Collaborations, and Agreements:
  • 8.7.3 SWOT Analysis
• 8.8 Agfa-Gevaert Group
  • 8.8.1 Company Overview
  • 8.8.2 Financial Analysis
  • 8.8.3 Segmental and Regional Analysis
  • 8.8.4 Research & Development Expenses
  • 8.8.5 SWOT Analysis
• 8.9 Honeywell International, Inc.
  • 8.9.1 Company Overview
  • 8.9.3 Segmental and Regional Analysis
  • 8.9.4 Research & Development Expenses
  • 8.9.5 Recent strategies and developments:
    • 8.9.5.1 Product Launches and Product Expansions:
  • 8.9.6 SWOT Analysis
• 8.10. McKesson Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Financial Analysis
  • 8.10.3 Segmental Analysis
  • 8.10.4 Research & Development Expense
  • 8.10.5 Recent strategies and developments:
    • 8.10.5.1 Partnerships, Collaborations, and Agreements:
    • 8.10.5.2 Acquisition and Mergers:
  • 8.10.6 SWOT Analysis

Chapter 9. Winning Imperative for Cardiovascular Information System Market